Cargando…
Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
The effect of paclitaxel combined with lobaplatin on the sensitivity of lung cancer cell line NCI-H446 through influencing the phosphatidylinositol 3-kinase (PI3K)/Akt pathway was investigated. The sensitivity of lobaplatin to NCI-H446 and the effect of paclitaxel and PI3K inhibitor LY294002 combine...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876435/ https://www.ncbi.nlm.nih.gov/pubmed/29616103 http://dx.doi.org/10.3892/ol.2018.8086 |
Search Result 1